GLP-1 Receptor Agonist Exenatide Protects Against Doxorubicin-Induced Cardiotoxicity Through the SIRT1 Pathway: An Electrocardiographic, 99mTc-PYP Scintigraphic, and Biochemical Study
<i>Background and Objectives:</i> This study was designed to evaluate the potential cardioprotective effect of Exenatide against doxorubicin (DOX)-induced myocardial injury in rats by assessing scintigraphic alterations together with oxidative stress and inflammation. <i>Materials and Methods:</i> T...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI AG
2026-01-01
|
| Colección: | Medicina |
| Materias: | |
| Acceso en línea: | https://www.mdpi.com/1648-9144/62/1/143 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|